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I. A B S T R A C T 
W h y the project was undertaken 
Recombinant retroviruses are one of the most commonly used means to transfer genes in gene 
therapy clinical trials because they can permanently integrate a therapeutic gene into the 
chromosomal D N A of target cells, resulting, in principle, in a long-term cure. Unfortunately, the 
current generation of recombinant retroviruses often are not able to both efficiently and 
selectively transfer genes to cells. Given the large number of important clinical applications, 
there is significant motivation to improve the efficiency and selectivity of retro viral-mediated 
gene transfer. Successful gene transfer with retroviruses requires the completion of a complex 
series of steps that begins with binding of the virus to the cell, transport of the bound virus to a 
location where its cellular receptors are expressed, followed by an interaction between the 
envelope proteins of the virus and their cellular receptors that leads to fusion of the virus with the 
cell and its entry into the cytoplasm. The mechanisms by which these steps of infection occur 
are poorly understood. It is important that we understand the mechanism by which retroviruses 
accomplish these early steps of infection because such knowledge could lead to the development 
of more efficient and selective strategies for genetically modifying cells in human gene therapy 
protocols, or for blocking infection by wild-type, pathogenic retroviruses. Therefore we 
undertook the Whitaker project in order to make progress towards our long-term goal, which is 
to establish engineering-based strategies for improving the functionality of recombinant 
retroviruses and lentiviruses for the purposes of human gene therapy. 
What research was performed 
W e had two major findings. First, we found that the route that retroviruses take within a cell is 
controlled by the receptors and co-receptors that they interact with when they bind to the cells 
they are infecting. In addition, the probability that they will successfully infect a cell is a 
function of the intracellular pa thway they take. We showed this be developing a novel 
experimental system that was composed of several cell lines that expressed retrovirus receptors 
that were identical in the portion that interacts with viruses, but different in the portion that 
controlled how the receptors were trafficked within the cell. W e engineered retroviruses to bind 
to these receptors, and studied the effect of receptor trafficking on virus trafficking and infection. 
Our second major finding was that retroviruses activate intracellular signals when they bind to 
cells. Specifically, they activate r a c l , a molecule that coordinates the formation of actin 
filaments within the cells. W e showed that viruses induce this signaling via proteoglycans on the 
surface of the virus and via integrins on the surfaces of the cells. W e are currently investigating 
the role that rac l activation has in retrovirus transduction. 
W h y the project was important 
The project was important because it showed that the molecules that are on the surface of 
retroviruses dictate how the viruses will traffick within the cell, and whether or not they induce 
intracellular signaling. Our findings suggest that by manipulat ing the surface properties of 
retroviruses, we should be able to control the signals they induce within cells, and how the 
viruses are transported within the cells, and thereby control the outcome of gene transfer, either 
making it more efficient, more selective, or both. The ability to do this will enable us to develop 
safer, more effective human gene therapy protocols. 
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